HopeStage
Back to all studies
CompletedNCT01198353

Switching to Ziprasidone for Schizophrenia or Schizoaffective Disorder

About this titleRead the official source — NCT01198353

This study evaluated the effectiveness of Ziprasidone for people with schizophrenia.

Medication studyAges 18–55South Korea
The study in practice

Understand this study

What did researchers investigate?

This study evaluated the effectiveness of Ziprasidone for people with schizophrenia.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Listed locations
Ansan and 5 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2010
Recruitment status
Completed
Enrollment listed in the registry
67
Sponsor
Soonchunhyang University Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
South Korea
Age range
From 18 Years to 55 Years
Official registry ID
NCT01198353
Official title
Show the full official title

Study Evaluating Effectiveness of Ziprasidone Using the Overlapped Switching Strategy in Patients With Schizophrenia or Schizoaffective Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Ansan · Bucheon-si · Incheon

1 more locations
  • Seoul

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

This study evaluated the effectiveness of Ziprasidone for people with schizophrenia.

Who is behind this study?

The study sponsor is Soonchunhyang University Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Ziprasidone.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies